The best provisioned smartphone for a global clinical trial is not necessarily the device with the longest specification sheet.
It is the device that can remain consistent, supportable and available throughout the study.
STK Helix is purpose-built for decentralised and hybrid clinical trials, eCOA, ePRO and patient-facing data collection. Unlike generic consumer smartphones, it is supported by an infrastructure model designed around clinical research requirements.
That includes:
- Hardware design and manufacturing
- OS customisation and device provisioning
- Certification and global deployment planning
- Physical SIM, eSIM and multi-network connectivity through STK Nexus™
- Replacement-device and lifecycle support
- A consistent environment for study applications and participant workflows
Helix is also the hardware foundation for STK Cortex™, the AI capability layer being developed to support areas such as on-device processing, multilingual engagement, reminders and biometric identity workflows.
The distinction matters. Clinical-trial devices are not accessories. They are part of the study infrastructure.
A provisioned-device strategy can help sponsors and technology partners reduce fragmentation, improve application control and provide access for participants who cannot or do not wish to use a personal smartphone.
STK has manufactured mobile devices since 1993. Helix brings that engineering and supply-chain experience into a platform designed to support clinical research workflows.
Speak with STK about your next global provisioned-device programme.